MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 75 filers reported holding MARKER THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,353 | +35.3% | 5,107 | +2.1% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 5,002 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 5,002 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 5,002 | +38.9% | 0.00% | – |
| Q4 2021 | $4,000 | -77.8% | 3,602 | -66.7% | 0.00% | – |
| Q3 2021 | $18,000 | -69.0% | 10,807 | -47.7% | 0.00% | – |
| Q2 2021 | $58,000 | -55.7% | 20,660 | -64.6% | 0.00% | – |
| Q1 2021 | $131,000 | +254.1% | 58,313 | +121.9% | 0.00% | – |
| Q4 2020 | $37,000 | +15.6% | 26,275 | +26.4% | 0.00% | – |
| Q3 2020 | $32,000 | -28.9% | 20,789 | -3.4% | 0.00% | – |
| Q2 2020 | $45,000 | +114.3% | 21,518 | +96.1% | 0.00% | – |
| Q1 2020 | $21,000 | -46.2% | 10,975 | -19.2% | 0.00% | – |
| Q4 2019 | $39,000 | -48.0% | 13,587 | -7.4% | 0.00% | – |
| Q3 2019 | $75,000 | +74.4% | 14,677 | +172.6% | 0.00% | – |
| Q2 2019 | $43,000 | -39.4% | 5,385 | -49.6% | 0.00% | – |
| Q1 2019 | $71,000 | – | 10,682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $2,986,000 | 1.05% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $337,000 | 0.24% |
| NEA Management Company, LLC | 10,714,285 | $10,179,000 | 0.21% |
| Long Focus Capital Management, LLC | 1,233,257 | $1,172,000 | 0.16% |
| Mandatum Life Insurance Co Ltd | 99,000 | $94,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 150,000 | $143,000 | 0.02% |
| AR ASSET MANAGEMENT INC | 71,500 | $68,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 590,118 | $561,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $21,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 324,216 | $308,000 | 0.01% |